AI + dimethyldiguanide

AI + dimethyldiguanide appears to refer to a combination product containing "dimethyldiguanide" (the chemical name for metformin) and an unspecified component abbreviated as "AI." Metformin (1,1-dimethylbiguanide hydrochloride) is a widely used oral antihyperglycemic agent in the biguanide class, primarily indicated for glycemic control in type 2 diabetes mellitus. Its mechanism of action includes decreasing hepatic glucose production, reducing intestinal absorption of glucose, and increasing insulin sensitivity by enhancing peripheral glucose uptake and utilization. Metformin acts mainly by inhibiting mitochondrial complex I activity, leading to activation of AMP-activated protein kinase (AMPK), which regulates multiple metabolic pathways[1][5][6][7]. The identity and function of the "AI" component are not specified in available sources; therefore, no information about its mechanism or indication can be provided.